Pavel O Bochkov

11PUBLICATIONS
44CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Haematological tumoursPharmacogenomicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 24, 2026
Impact of Cytochrome P450 and P-glycoprotein Gene Polymorphisms on the Risk of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban.

|Nov 28, 2025
Exome-wide association study of bleeding events in patients receiving direct oral anticoagulants.

Dmitry A Sychev, Anastasiia A Buianova, Sherzod P Abdullaev

|Oct 29, 2025
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation.

Andrey P Kondrakhin, Sherzod P Abdullaev, Ivan V Sychev

|Aug 27, 2025
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management.

Shokhrukh P Abdullaev, Maksim N Shatokhin, Pavel O Bochkov

|Feb 13, 2025
CYP2D6 genetic polymorphisms impact on tamsulosin efficacy and safety in patients with benign prostatic hyperplasia.

Shokhrukh Abdullaev, Maksim Shatokhin, Ivan Sychev

|Apr 06, 2022
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.

Eric Rytkin, Irina V Bure, Pavel O Bochkov

Pageof 2

Frequent Collaborators

8 joint publications

Dmitry Sychev

5 joint publications

Eric Rytkin

5 joint publications

Karin Mirzaev

4 joint publications

Olga Ostroumova